Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

REVEALED: Renaissance capital - The Real Truth

Anthropic hits a $380B valuation as it heightens competition with OpenAI

Artificial intelligence company Anthropic says it is now valued at $380 billion

The Independent UK

Citi edges closer to Russia exit, bracing for over €1bn hit

Citi has secured internal approvals to sell its remaining business in Russia to Renaissance Capital, moving closer to an exit from the market after years of delays.

Euronews

Medline IPO: Should You Buy MDLN Stock?

The Medline IPO turned out to be the biggest offering of the year, with the medical supply company making its market debut on December 17.

Kiplinger

From analysis to the latest developments in health,
read the most diverse news in one place.

Citigroup cleared to exit Russia as Kremlin keeps tight grip on company departures

A presidential order allowing Citigroup to sell its Russian unit to Renaissance Capital underscores Moscow’s control over foreign asset sales as Western lenders continue their slow retreat.

Euronews

Government shutdown threatens to stall the recovery in the IPO market

The U.S. government shutdown could raise a caution flag for private companies considering a move to the public market for investors

The Independent UK

Government Shutdown Puts IPO Resurgence at Risk

The IPO market has been sizzling in recent months, but the government shutdown threatens to put a short-term halt to public offerings. Here's why.

Kiplinger

StubHub IPO: Should You Buy STUB Stock?

The highly anticipated StubHub IPO came and went, with shares of the online ticket marketplace making their market debut Wednesday, September 17.

Kiplinger

Read news from The Economist, FT, and more,
with one subscription

Klarna IPO: Should You Buy KLAR Stock?

The Klarna IPO is one of the biggest offerings of the year, with the buy now, pay later firm going public on September 10.

Kiplinger

Bullish IPO: Should You Buy BLSH Stock?

Wall Street is buzzing about the Bullish IPO. The Peter Thiel-backed crypto company went public on August 13, and BLSH stock nearly doubled in its market debut.

Kiplinger

The IPO market is booming—and more big listings like Klarna and StubHub could come this fall

More companies have gone public this year than any time since 2021.

Fortune

CoreWeave IPO: Should You Buy CRWV Stock?

The CoreWeave IPO was the biggest public offering of the year so far, with the AI cloud company making its market debut on Friday, March 28.

Kiplinger

Lower Rates, Surging Stock Market Fail To Ignite US IPO Market

Public listings on Wall Street have seen a slow comeback in 2024 despite a resilient US economy, a long-awaited interest rate cut by the central bank and stock valuations hitting record highs.

International Business Times

The IPO market is gaining steam. Who might list later this year?

Big debuts from Reddit and Astera Labs are raising hope the IPO market has finally rebounded. But it’s still not the soaring, go-go days of 2021.

Fortune

IPO Market Shows Promising Growth Amid Cooling Inflation

From a lackluster 2022 to a rebound in 2023, the IPO market shows signs of life. Analysts predict a solid pickup in 2024 as inflation cools and interest ra...

Top News

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger

What Klaviyo, Instacart and Arm Earnings Mean for the IPO Market?

The most highly anticipated tech IPOs have struggled following their red-hot starts. What does that mean for the IPO market going forward?

Fortune

3 lessons from September’s 3 big IPOs

The meager post-IPO performance of Arm, Instacart, and Klaviyo means that “the first half of 2024 is the new second half of 2023” for other IPO hopefuls, according to Renaissance Capital’s Matthew Kennedy.

Fortune

Arm, Instacart, Klaviyo to lead IPO market this fall

Positive debuts from the trio of tech stars could help kick open the IPO floodgates

Kiplinger

Johnson & Johnson Spins Off Kenvue in Biggest IPO Haul Since 2021

Johnson & Johnson rips off Band-Aid and spits out Listerine in a bid to boost margins.

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

IPO outlook: After a boom and bust in recent years, 2023 may be the year unicorns Stripe, Chime, and Instacart list shares

The IPO pipeline closed in 2022, but there’s reason to believe that it may reopen as 2023 gets underway.

Kiplinger

Hot Upcoming IPOs to Watch

The most exciting upcoming IPOs include data intelligence platform Databricks and Elon Musk's SpaceX.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.